Research News

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online 
  • Blocking pain at the source : Hormone therapy rewires nerve signals in aging spines
    5 February 2026

    Blocking pain at the source : Hormone therapy rewires nerve signals in aging spines

    Low back pain (LBP) is one of the most common health problems worldwide, affecting people of all ages and placing a heavy burden on healthcare systems. Many patients experience persistent discomfort that interferes with work, sleep, and daily activities. Yet in most cases, doctors cannot identify a clear structural cause, making long-term treatment difficult.

  • 4 February 2026
    Breakthrough in HIV Vaccine Research : Single-Shot Candidate Shows Neutralizing Success in Primates
    Scientists at The Wistar Institute have reported a major step forward in HIV vaccine development with a novel vaccine candidate that can induce neutralizing antibodies after a single immunization in nonhuman primates, an achievement never before demonstrated in the field.
  • 31 January 2026
    Wearable Hydrogel Breakthrough for Real-Time Cardio & Respiration Tracking
    Scientists have developed an advanced MXene-based wearable hydrogel sensor capable of continuous heart rate and respiratory monitoring under extreme conditions such as high heat, humidity and vigorous exercise.
  • 26 January 2026
    Scientists Decode How Cancer Cells Evade the Immune System, Opening Doors for Future Therapies

    An international team of researchers has uncovered a crucial mechanism that allows certain cancer cells to hide from the body’s immune defenses, a discovery that could reshape future cancer treatments. The study, led by scientists at Julius-Maximilians-Universität Würzburg (JMU) in collaboration with partners in the United States, reveals how the powerful cancer-driving protein MYC not only fuels tumor growth but also helps tumors remain undetected by the immune system.

  • 26 January 2026
    Heavy Lifetime Alcohol Use Linked to Higher Colorectal Cancer Risk, New Research Shows

    A new epidemiological study reported today finds that consistent heavy alcohol consumption over a lifetime is associated with a significantly increased risk of colorectal cancer, particularly rectal cancer, while reducing or quitting drinking may lower that risk. The findings were published online in the peer-reviewed journal Cancer.

  • 17 January 2026
    New Gut Protein Intelectin-2 Shows Promise as Natural Antimicrobial Defender
    Scientists have discovered an important protein in the human gut that can help protect the body from many harmful bacteria. This protein, called intelectin-2, acts as both a defensive barrier-builder and a bacteria-fighting molecule offering new insights into how the body defends itself at mucosal surfaces and pointing to possible future treatments against infections and antibiotic-resistant microbes.
  • 7 January 2026
    Dual-Drug Breakthrough: A new pathway to treat Liver Fibrosis
    Researchers have identified a promising new treatment strategy for liver fibrosis, a chronic condition that can lead to cirrhosis and liver cancer, by combining two well-known drugs. Preliminary findings suggest that using silybin together with carvedilol produces a powerful synergistic effect significantly stronger than either drug alone, against the cellular processes that drive scar tissue formation in the liver.
  • 7 January 2026
    Infant gut molecules offer clues to type 1 Diabetes risk
    In a groundbreaking study, scientists have uncovered a new class of gut-derived molecules in infancy that could reshape how researchers understand the development of type 1 diabetes. The international research team, led by experts at the University of Turku and Örebro University, investigated stool samples from more than 300 children between the ages of 3 and 36 months, all of whom had a genetic predisposition for type 1 diabetes.
  • 3 January 2026
    Breakthrough study finds traditional Medicinal Fungus shows strong antidiabetic potential

    A new peer-reviewed study has revealed that Sanghuangporus quercicola, a medicinal fungus long used in traditional practices across Asia, produces significantly varied secondary metabolites under different cultivation conditions, with notable in vitro antidiabetic activity emerging from the analyses.

  • 1 January 2026
    Enveric Biosciences Secures Key U.S. Patent to Broaden Neuropsychiatric Drug Pipeline
    Enveric Biosciences, a biotechnology company developing next-generation small-molecule neuroplastogenic therapeutics, announced the issuance of a significant new U.S. patent that enhances its intellectual property portfolio and expands opportunities for advancing treatments in mental health disorders.
Subscribe to Research News